President Donald Trump announced agreements with Eli Lilly and Novo Nordisk to reduce Medicare copays for GLP-1 drugs like Wegovy and Zepbound from $1,350 to $50 monthly, advancing his ‘Make America Healthy Again’ agenda amid an obesity crisis affecting 42% of U.S. adults.
The Oval Office event on Thursday paused for 20 minutes when Novo Nordisk executive Gordon Findlay fainted, with Dr. Mehmet Oz providing immediate aid and Robert F. Kennedy Jr. fetching medical help.
Trump resumed the briefing, confirming Findlay’s recovery, while the incident sparked widespread social media reactions.
